Comparative effectiveness of 8 versus 12 weeks of Ombitasvir/Paritaprevir/ritonavir and Dasabuvir in treatment-naïve patients infected with HCV genotype 1b with non-advanced hepatic fibrosis.

Zarębska-Michaluk D, Piekarska A, Jaroszewicz J, Klapaczyński J, Mazur W, Krygier R, Belica-Wdowik T, Baka-Ćwierz B, Janczewska E, Pabjan P, Dobracka B, Lorenc B, Tudrujek-Zdunek M, Tomasiewicz K, Sitko M, Garlicki A, Czauż-Andrzejuk A, Citko J, Dybowska D, Halota W, Pawłowska M, Laurans Ł, Deroń Z, Buczyńska I, Simon K, Białkowska J, Tronina O, Flisiak R

Open source

DOI: 10.1016/j.advms.2019.09.002
Published: 2020 Mar
Container: Advances in medical sciences
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.advms.2019.09.002,
  title = {Comparative effectiveness of 8 versus 12 weeks of Ombitasvir/Paritaprevir/ritonavir and Dasabuvir in treatment-naïve patients infected with HCV genotype 1b with non-advanced hepatic fibrosis.},
  author = {Zarębska-Michaluk D and Piekarska A and Jaroszewicz J and Klapaczyński J and Mazur W and Krygier R and Belica-Wdowik T and Baka-Ćwierz B and Janczewska E and Pabjan P and Dobracka B and Lorenc B and Tudrujek-Zdunek M and Tomasiewicz K and Sitko M and Garlicki A and Czauż-Andrzejuk A and Citko J and Dybowska D and Halota W and Pawłowska M and Laurans Ł and Deroń Z and Buczyńska I and Simon K and Białkowska J and Tronina O and Flisiak R},
  year = {2020},
  journal = {Advances in medical sciences},
  doi = {10.1016/j.advms.2019.09.002},
  url = {https://doi.org/10.1016/j.advms.2019.09.002}
}

RIS

TY  - JOUR
TI  - Comparative effectiveness of 8 versus 12 weeks of Ombitasvir/Paritaprevir/ritonavir and Dasabuvir in treatment-naïve patients infected with HCV genotype 1b with non-advanced hepatic fibrosis.
AU  - Zarębska-Michaluk D
AU  - Piekarska A
AU  - Jaroszewicz J
AU  - Klapaczyński J
AU  - Mazur W
AU  - Krygier R
AU  - Belica-Wdowik T
AU  - Baka-Ćwierz B
AU  - Janczewska E
AU  - Pabjan P
AU  - Dobracka B
AU  - Lorenc B
AU  - Tudrujek-Zdunek M
AU  - Tomasiewicz K
AU  - Sitko M
AU  - Garlicki A
AU  - Czauż-Andrzejuk A
AU  - Citko J
AU  - Dybowska D
AU  - Halota W
AU  - Pawłowska M
AU  - Laurans Ł
AU  - Deroń Z
AU  - Buczyńska I
AU  - Simon K
AU  - Białkowska J
AU  - Tronina O
AU  - Flisiak R
PY  - 2020
JO  - Advances in medical sciences
DO  - 10.1016/j.advms.2019.09.002
UR  - https://doi.org/10.1016/j.advms.2019.09.002
ER  -

APA

D, Z., A, P., J, J., J, K., W, M., R, K., T, B., B, B., E, J., P, P., B, D., B, L., M, T., K, T., M, S., A, G., A, C., J, C., D, D., W, H., M, P., Ł, L., Z, D., I, B., K, S., J, B., O, T., & R, F. (2020). Comparative effectiveness of 8 versus 12 weeks of Ombitasvir/Paritaprevir/ritonavir and Dasabuvir in treatment-naïve patients infected with HCV genotype 1b with non-advanced hepatic fibrosis.. Advances in medical sciences. https://doi.org/10.1016/j.advms.2019.09.002

Source records

pubmed · retrieved 2026-09-26T22:33:33.154Z
europe-pmc · retrieved 2026-09-26T22:33:33.159Z